Published online Jul 24, 2025. doi: 10.5306/wjco.v16.i7.106687
Revised: March 17, 2025
Accepted: March 27, 2025
Published online: July 24, 2025
Processing time: 140 Days and 2.3 Hours
This editorial comment on the article by Agidew et al in the recent issue of the World Journal of Clinical Oncology. Breast cancer remains a growing challenge in Ethiopia, where high mortality results from low awareness, delayed diagnosis, and restricted healthcare access. Agidew et al report that women with a family history of breast disease exhibit significantly higher levels of knowledge (83.9% vs 10.5%), more positive attitudes (49% vs 32.1%), and greater engagement in pre
Core Tip: In Ethiopia, a study reveals that family history (FH) significantly boosts awareness and preventive practices among women, with those reporting FH demonstrating 83.9% knowledge compared to only 10.5% among those without. However, 69%-79% of participants live below the poverty line, underscoring critical socioeconomic barriers. Education, income, and insurance emerge as strong predictors of positive outcomes, suggesting that expanding community health insurance could be a pivotal strategy. This editorial advocates for deploying community-based approaches, culturally tailored education, and AI-powered education tools, to bridge knowledge gaps in resource-limited settings and transform awareness into action globally.
- Citation: Zhou S. Bridging knowledge gaps in breast cancer prevention: Insights from Ethiopia. World J Clin Oncol 2025; 16(7): 106687
- URL: https://www.wjgnet.com/2218-4333/full/v16/i7/106687.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i7.106687
Breast cancer remains a critical global health challenge. According to GLOBOCAN 2022, female breast cancer is the second most common cancer worldwide, with 2.3 million new cases annually, and the leading cause of cancer-related deaths among women[1]. The disease shows notable disparities between high-income countries (HICs) and low- and middle-income countries (LMICs). While HICs have reduced mortality through early detection and advanced treatment, LMICs like Ethiopia face rising incidence and mortality rates[1]. Notably, Ethiopia’s breast cancer mortality rate is twice that of the United States despite a 60% lower incidence, a disparity driven by low awareness, delayed diagnosis, and limited healthcare access[1].
Breast cancer is a significant heterogeneous disease with a multifaceted etiology involving genetic, environmental, and lifestyle factors. A recent population-based study found that pathogenic variants in 12 established breast cancer–predisposition genes in 5.03% of case patients and in 1.63% of controls[2]. Individuals with a family history (FH) of breast cancer, particularly those with an affected first-degree relative, face significantly higher risk[3]. Early-stage breast cancer can be cured with local-regional therapies like surgery and radiotherapy, with or without systemic treatments, while advanced breast cancer with distant metastases remains incurable even with systemic therapy management[4]. In Ethiopia, 71% of breast cancer patients diagnosed at stages III or IV, significantly increasing mortality risk[5]. While screening helps detect cancer early, individuals in LMICs demonstrate varying levels of knowledge, attitudes, and preventive practices regarding breast cancer.
This editorial comment on the article by Agidew et al[6] in a recent issue of the World Journal of Clinical Oncology, focusing on the interplay between FH, socioeconomic factors, and breast cancer prevention behaviors in Ethiopia, with implications for similar resource-limited settings worldwide.
A recent study by Agidew et al[6] in the World Journal of Clinical Oncology offers critical insights into how FH of breast disease shapes knowledge, attitudes, and preventive practices among reproductive-age women in Northeast Ethiopia. By focusing on a rural region with scarce data, this study highlights the role of personal experience in driving health behaviors and identifies actionable socioeconomic factors for public health strategies in resource-limited settings[6].
Agidew et al[6] employed validated questionnaires and systematic sampling to assess differences between women with and without FH of breast disease[6]. Their findings demonstrated that women with FH demonstrated significantly higher levels of knowledge (83.9% vs 10.5%), more positive attitudes (49% vs 32.1%), and greater engagement in preventive practices (74.1% vs 16.7%) compared to their counterparts without FH. These disparities suggest that direct exposure to breast disease within a family serves as a powerful motivator, fostering awareness and proactive behaviors that might otherwise remain dormant in the absence of personal relevance.
Beyond the influence of FH, the study found educational status, monthly income, and community health insurance as significant predictors of knowledge, attitudes, and preventive practices. Women with secondary or higher education, those living above the poverty line, and those with health insurance were far more likely to exhibit favorable outcomes across all three domains. These findings align with global evidence linking social determinants to health literacy and preventive behaviors. Additionally, their findings highlight a critical economic disparity in this region, where 69.2% of women with FH and an even higher 78.9% without FH live below the poverty line, creating substantial barriers that prevent most women from translating awareness into actionable healthcare decisions.
This study reveals that women with FH of breast disease demonstrate better knowledge, attitudes, and preventive practices regarding breast cancer. These women could serve as effective community advocates for awareness. However, significant socioeconomic barriers exist, with 69%-79% of women living below the poverty line. Education level, income, and health insurance status strongly predict health outcomes, suggesting that community health insurance expansion could help bridge the gap between awareness and action. These findings reflect broader challenges in low and middle-income countries like Ethiopia, where breast cancer accounts for 33% of female cancers but healthcare systems remain primarily focused on communicable diseases rather than cancer prevention and treatment.
While this study advances understanding of breast cancer prevention in LMICs, there are several limitations warrant attention. First, the study’s cross-sectional design limits causal links between FH and breast cancer awareness. Longitudinal studies could track women over time to determine if FH directly enhances knowledge and practices or reflects factors like healthcare access. Qualitative methods, such as interviews or focus groups, combined with surveys, could uncover cultural beliefs and barriers missed by quantitative data. Community trials testing educational strategies could identify effective approaches, especially for women without FH. Culturally tailored tools, validated with local input, would improve measurement of knowledge, attitudes, and practices. Using observed skills assessments, such as direct evaluations of breast self-examination, or relying on clinical records rather than self-reports would enhance reliability. Despite female interviewers, social desirability bias may persist; anonymous surveys or mixed-methods approaches could address this. Finally, implementation science could adapt and scale interventions within Ethiopia’s resource-constrained healthcare system, translating findings into practice.
Second, reliance on American Cancer Society guidelines raises questions about applicability to Ethiopia’s sociocultural context. International guidelines often reflect Western healthcare contexts and may not fully account for the unique cultural, social, and healthcare realities in Ethiopia. Future work should focus on adapting these guidelines to incorporate local health beliefs, communication practices, and social structures. For instance, educational campaigns could integrate Ethiopia's communal decision-making structures by training respected community leaders, religious figures, or "health ambassadors" to disseminate information. Leveraging oral traditions, such as storytelling or radio dramas in local languages, could make messages more relatable than text-heavy materials. Furthermore, preventive practices like self-exams should be reframed within culturally acceptable norms. In rural areas, community health workers could teach self-examination during maternal health visits, normalizing it as part of holistic care. Collaborations with traditional healers could also help in recognizing early signs and referring patients, thereby building trust within the community.
Third, a puzzling negative link between education status and knowledge, attitude, and preventive practices suggests possible data errors or confounding, requiring further clarification. These findings contradict established literature and the authors' own conclusions, which state that higher education is associated with better outcomes. This discrepancy raises questions about potential data errors, statistical analysis issues, or unidentified confounding variables. Clarification from the authors on these contradictory findings is essential before their results can reliably inform interventions.
Fourth, a notable demographic imbalance exists between the study groups. Women with a FH of breast disease were predominantly rural residents (76.2%), while the non-FH group had a majority of urban residents (56.5%). This substantial rural/urban distribution difference could significantly confound the results, as urban residents typically have better access to healthcare information and services. The authors did not adequately address this potential confounder in their multivariate analysis, making it difficult to determine whether the observed differences in knowledge, attitudes, and practices are truly attributable to FH or simply reflect urban/rural disparities in healthcare access and education.
Agidew et al's findings represent a clear call to action for breast cancer prevention in Ethiopia and similar settings. While FH naturally heightens awareness, effective public health strategies must extend this vigilance to all women[6]. Targeted educational programs should be paired with practical measures, including accessible screening services and expanded health insurance coverage, to ensure knowledge transforms into preventive action.
In Ethiopia's context, where healthcare systems face the dual burden of infectious and chronic diseases with limited resources, these findings offer valuable direction. They highlight that effective breast cancer control requires both individual empowerment through education and systemic improvements in healthcare access. The evidence from Wollo provides a foundation that policymakers, healthcare providers, and researchers must now build upon with context-appropriate interventions that address both awareness and the socioeconomic barriers that currently prevent action.
Reports from HICs reveal distinct patterns. For example, Lin et al[7] found no significant association between FH and cancer attitudes in Ohio, United States (P = 0.11), with education level emerging as the dominant predictor of preventive behaviors[7]. Similarly, Ahmed et al[8] found a belief-action gap among Saudi healthcare providers, with 91.4% endorsing screening while actual uptake remained low.
Social determinants further shape these outcomes. Agidew et al[6] demonstrated that health insurance coverage strongly predicted preventive practices (Adjusted odds ratios = 4.59)[6], aligning with Lin et al’s emphasis on education[7]. Despite these findings, structural barriers persist in Agidew et al’s Ethiopian cohort, 69.2% of FH-positive and 78.9% of FH-negative women lived below the poverty line[6]. Meanwhile, Sayed et al’s meta-analysis reported that clinical breast examination training improved early-stage detection in LMICs [relative risk (RR) = 1.44], though its impact on mortality remained inconclusive (RR = 0.88)[8,9]. These disparities highlight a critical contrast: While FH drives awa
Emerging technologies like artificial intelligence (AI) chatbots, such as Claude, ChatGPT, and Gemini, offer complementary solutions for LMICs. Recent studies show these AI chatbots can outperform physicians and surgeons in specific knowledge domains[10-12]. Furthermore, AI chatbots have significant potential as cancer education tools for conditions such as myeloma and prostate cancer[12,13]. These technologies hold particular promise in LMICs where access to quality healthcare is limited[14]. First, AI can provide reliable information on breast cancer prevention and screening. Haver et al[15] evaluated ChatGPT’s performance in answering common questions about breast cancer prevention and screening[15]. They found that ChatGPT provided appropriate responses for 22 out of 25 questions (88%)[15]. These results in
To transform awareness into action, Ethiopia could implement strategies such as expanding health insurance, offering culturally tailored education, utilizing AI-powered education tools, and improving healthcare provider training. Community-based organizations and local partnerships are essential. Trusted community health workers can extend breast health education, particularly in rural areas where many women with a FH reside. Religious institutions, women’s groups, and breast cancer survivors can help normalize discussions about breast health and act as effective ambassadors. Moreover, engaging traditional healers, who are often the first point of contact for health concerns, can establish reliable referral pathways to formal healthcare. This community-centered approach, combined with structural healthcare reforms, offers a practical model to bridge the gap between awareness and action, ultimately improving outcomes for women regardless of FH.
1. | Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229-263. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 5690] [Cited by in RCA: 7677] [Article Influence: 7677.0] [Reference Citation Analysis (2)] |
2. | Hu C, Hart SN, Gnanaolivu R, Huang H, Lee KY, Na J, Gao C, Lilyquist J, Yadav S, Boddicker NJ, Samara R, Klebba J, Ambrosone CB, Anton-Culver H, Auer P, Bandera EV, Bernstein L, Bertrand KA, Burnside ES, Carter BD, Eliassen H, Gapstur SM, Gaudet M, Haiman C, Hodge JM, Hunter DJ, Jacobs EJ, John EM, Kooperberg C, Kurian AW, Le Marchand L, Lindstroem S, Lindstrom T, Ma H, Neuhausen S, Newcomb PA, O'Brien KM, Olson JE, Ong IM, Pal T, Palmer JR, Patel AV, Reid S, Rosenberg L, Sandler DP, Scott C, Tamimi R, Taylor JA, Trentham-Dietz A, Vachon CM, Weinberg C, Yao S, Ziogas A, Weitzel JN, Goldgar DE, Domchek SM, Nathanson KL, Kraft P, Polley EC, Couch FJ. A Population-Based Study of Genes Previously Implicated in Breast Cancer. N Engl J Med. 2021;384:440-451. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 548] [Cited by in RCA: 524] [Article Influence: 131.0] [Reference Citation Analysis (0)] |
3. | Xu H, Xu B. Breast cancer: Epidemiology, risk factors and screening. Chin J Cancer Res. 2023;35:565-583. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 33] [Reference Citation Analysis (0)] |
4. | Hong R, Xu B. Breast cancer: an up-to-date review and future perspectives. Cancer Commun (Lond). 2022;42:913-936. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 121] [Cited by in RCA: 175] [Article Influence: 58.3] [Reference Citation Analysis (0)] |
5. | Bekele K, Nugusu F, Beressa G, Hollis T, Ferreres A, Duguma D, Guta B, Gutnik L, Lemesse B, Gezahegn H. Proportion of early-stage breast cancer at diagnosis in Ethiopia: a systematic review and meta-analysis. BMC Cancer. 2024;24:1017. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 1] [Reference Citation Analysis (0)] |
6. | Agidew MM, Cherie N, Damtie Z, Adane B, Derso G. Impact of family history of breast disease on knowledge, attitudes, and breast cancer preventive practices among reproductive-age women. World J Clin Oncol. 2025;16:101788. [RCA] [DOI] [Full Text] [Full Text (PDF)] [Cited by in CrossRef: 1] [Cited by in RCA: 2] [Article Influence: 2.0] [Reference Citation Analysis (0)] |
7. | Lin L, Zhang X, Yu M, Bernardo B, Adeyanju T, Paskett ED. The relationship between family history of cancer and cancer attitudes & beliefs within the Community Initiative Towards Improving Equity and Health Status (CITIES) cohort. PLoS One. 2023;18:e0287629. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 1] [Cited by in RCA: 1] [Article Influence: 0.5] [Reference Citation Analysis (0)] |
8. | Ahmed GY, Al Mutair A, Bashir S, Acunin R, Al Aljabr N, Alnumari R, Alarab G, Hussein SM, Saha C, Al-Jamea LH, Woodman A, Almusalami E. Attitudes and Practice of Health Care Providers Toward Cancer Screening: A Cross-sectional Multicenter Study, Saudi Arabia. J Epidemiol Glob Health. 2022;12:383-389. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 4] [Reference Citation Analysis (0)] |
9. | Sayed S, Ngugi AK, Nwosu N, Mutebi MC, Ochieng P, Mwenda AS, Salam RA. Training health workers in clinical breast examination for early detection of breast cancer in low- and middle-income countries. Cochrane Database Syst Rev. 2023;4:CD012515. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 2] [Cited by in RCA: 7] [Article Influence: 3.5] [Reference Citation Analysis (0)] |
10. | Zhou S, Luo X, Chen C, Jiang H, Yang C, Ran G, Yu J, Yin C. The performance of large language model-powered chatbots compared to oncology physicians on colorectal cancer queries. Int J Surg. 2024;110:6509-6517. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in RCA: 13] [Reference Citation Analysis (0)] |
11. | Liu J, Zheng J, Cai X, Wu D, Yin C. A descriptive study based on the comparison of ChatGPT and evidence-based neurosurgeons. iScience. 2023;26:107590. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 15] [Cited by in RCA: 26] [Article Influence: 13.0] [Reference Citation Analysis (0)] |
12. | Saba L, Fu CL, Khouri J, Faiman B, Anwer F, Chaulagain CP. Evaluating ChatGPT as an educational resource for patients with multiple myeloma: A preliminary investigation. Am J Hematol. 2024;99:1205-1207. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 2] [Reference Citation Analysis (0)] |
13. | Gibson D, Jackson S, Shanmugasundaram R, Seth I, Siu A, Ahmadi N, Kam J, Mehan N, Thanigasalam R, Jeffery N, Patel MI, Leslie S. Evaluating the Efficacy of ChatGPT as a Patient Education Tool in Prostate Cancer: Multimetric Assessment. J Med Internet Res. 2024;26:e55939. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 17] [Reference Citation Analysis (0)] |
14. | Wang X, Sanders HM, Liu Y, Seang K, Tran BX, Atanasov AG, Qiu Y, Tang S, Car J, Wang YX, Wong TY, Tham YC, Chung KC. ChatGPT: promise and challenges for deployment in low- and middle-income countries. Lancet Reg Health West Pac. 2023;41:100905. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 29] [Cited by in RCA: 44] [Article Influence: 22.0] [Reference Citation Analysis (1)] |
15. | Haver HL, Ambinder EB, Bahl M, Oluyemi ET, Jeudy J, Yi PH. Appropriateness of Breast Cancer Prevention and Screening Recommendations Provided by ChatGPT. Radiology. 2023;307:e230424. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 142] [Reference Citation Analysis (0)] |
16. | Haver HL, Gupta AK, Ambinder EB, Bahl M, Oluyemi ET, Jeudy J, Yi PH. Evaluating the Use of ChatGPT to Accurately Simplify Patient-centered Information about Breast Cancer Prevention and Screening. Radiol Imaging Cancer. 2024;6:e230086. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 7] [Cited by in RCA: 21] [Article Influence: 21.0] [Reference Citation Analysis (0)] |
17. | Winterstein JT, Abels J, Kuehn A, Carl N, Wies C, Brinker TJ. AI-generated cancer prevention influencers can target risk groups on social media at low cost. Eur J Cancer. 2025;217:115251. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 2] [Reference Citation Analysis (0)] |